Adipic Acid

Adipic Acid

SCHEMBL769185

CCC(O)O.O=C(O)CCCCC(=O)O

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC18A2SLC6A2SLC6A3

The experimentally established mechanism targets of Adipic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.62
LMNA P02545 2/20 0.61
GPR84 Q9NQS5 7/20 0.59
PPARG P37231 7/20 0.59
PPARD Q03181 7/20 0.59
PPARA Q07869 7/20 0.59
HDAC11 Q96DB2 5/20 0.59
TSHR P16473 5/20 0.59
PTPN1 P18031 3/20 0.59
ALDH1A1 P00352 2/20 0.59
TLR2 O60603 2/20 0.59
TDP1 Q9NUW8 2/20 0.59
FABP4 P15090 2/20 0.59
FFAR1 O14842 2/20 0.59
FFAR4 Q5NUL3 2/20 0.59
SLC22A6 Q4U2R8 2/20 0.59
SLC22A8 Q8TCC7 1/20 0.59
MEN1 O00255 1/20 0.59
ESR1 P03372 1/20 0.59
ALOX15 P16050 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adipic Acid SCHEMBL29895908 1.00 AKR1B1 (0.62) AKR1B1LMNAGPR84PPARGPPARD
Sebacic Acid SCHEMBL2181971 0.97 GPR84 (0.64) AKR1B1LMNAGPR84PPARGPPARD
Azelaic Acid SCHEMBL28166594 0.97 GPR84 (0.64) AKR1B1LMNAGPR84PPARGPPARD
Glutarate SCHEMBL28037031 0.94 SLC22A6 (0.61) AKR1B1LMNAGPR84PPARGPPARD
Hexanoate SCHEMBL25362962 0.93 AKR1B1 (0.76) AKR1B1LMNAGPR84PPARGPPARD
Adipic Acid SCHEMBL11438883 0.93 GPR84 (0.54) AKR1B1LMNAGPR84PPARGPPARD
Myristic Acid SCHEMBL769296 0.91 GPR84 (0.77) AKR1B1LMNAGPR84PPARGPPARD
Dodecanoate SCHEMBL4241627 0.91 GPR84 (0.77) AKR1B1LMNAGPR84PPARGPPARD
Stearic Acid SCHEMBL374745 0.91 GPR84 (0.77) AKR1B1LMNAGPR84PPARGPPARD
SCHEMBL6746328 0.91 FFAR4 (0.59) AKR1B1LMNAGPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 876 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110534239-A A kind of ageing-resistant photovoltaic cable ANHUI CABLE CO LTD 2019-12-03 CN claimed
CN-110066525-A A kind of environment protection architecture template 李守征 2019-07-30 CN claimed
CN-109971252-A A kind of UV ink-jet ink and preparation method thereof 传美讯电子科技(珠海)有限公司 2019-07-05 CN claimed
CN-109834916-A A kind of electric support Shooting Technique 山东菏泽振华精密模具有限公司 2019-06-04 CN claimed
CN-107266884-B A kind of 3D printing material of totally biodegradable and preparation method thereof 吴新贤 2019-03-15 CN claimed
CN-109422925-A A kind of anti-oilcloth of PVC coating 于银强 2019-03-05 CN claimed
CN-109337172-A A kind of enhanced plastic bucket 江门市恒荣塑料制品有限公司 2019-02-15 CN claimed
CN-106192443-B A kind of anion ecological artificial leather and preparation method thereof 南通中豪超纤制品有限公司 2019-02-01 CN claimed
CN-109233072-A A kind of PE plastic barrel 江门市恒荣塑料制品有限公司 2019-01-18 CN claimed
CN-109112846-A A kind of high-strength abrasion-proof plated film PVC artificial leather 南通中奥车用新材料有限公司 2019-01-01 CN claimed
EP-1991515-A2 BIO-DERIVED 1,3-PROPANEDIOL AND ITS CONJUGATE ESTERS AS NATURAL AND NON IRRITATING SOLVENTS FOR BIOMASS-DERIVED EXTRACTS FRAGRANCE CONCENTRATES, AND OILS DuPont Tate & Lyle Bio Products Company, LLC (US) 2008-11-19 EP claimed
WO-2008123845-A2 COMPOSITIONS COMPRISING MONO AND DI ESTERS OF BIOLOGICALLY-BASED 1.3-PROPANEDIOL DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC (US) 2008-10-16 WO claimed
US-20070213247-A1 Detergent and liquid soap compositions comprising biologically-based mono and di esters DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC 2007-09-13 US claimed
US-20070207939-A1 Compositions comprising mono and di esters of biologically-based 1,3-propanediol DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC 2007-09-06 US claimed
US-20070202126-A1 biodegradable; improved anthropogenic carbon dioxide emission profile BARCLAYS BANK PLC, AS COLLATERAL AGENT 2007-08-30 US claimed
US-20070202580-A1 Synthesis of mono and di esters from biologically-produced 1,3-propanediol BARCLAYS BANK PLC, AS COLLATERAL AGENT 2007-08-30 US claimed
US-20070203276-A1 Plasticizers comprising biologically-based mono and di esters DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC 2007-08-30 US claimed
US-20070202073-A1 Personal care and cosmetics compositions comprising biologically-based mono and di esters DUPONT TATE &LYLE BIO PRODUCTS COMPANY, LLC 2007-08-30 US claimed
US-20070203323-A1 Food compositions comprising biologically-based biodegradable 1,3-propanediol esters DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC 2007-08-30 US claimed
WO-2007095262-A2 BIO-DERIVED 1,3-PROPANEDIOL AND ITS CONJUGATE ESTERS AS NATURAL AND NON IRRITATING SOLVENTS DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC (US) 2007-08-23 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070202580-A1 Synthesis of mono and di esters from biologically-produced 1,3-propanediol DECR1, DECR2, HSD17B12 AKR1B1 203/4885LMNA 3804/4885GPR84 1943/4885
US-20070202126-A1 biodegradable; improved anthropogenic carbon dioxide emission profile BMP2, PGD, EBP AKR1B1 1405/4885LMNA 1877/4885GPR84 3746/4885
US-20070202073-A1 Personal care and cosmetics compositions comprising biologically-based mono and di esters PBDC1, CUTA, EBP AKR1B1 167/4885LMNA 1332/4885GPR84 2433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.